Cargando…

Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion

Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after allogeneic hematopoietic stem-cell transplantation (alloHSCT). However, DLI harbors the risk of increased non-relapse mortality due to the co-occurrence of graft-versus-host disease (GVHD). GVHD onset may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Jessica, Kuhlmann, Leonie, Xiao, Yankai, Raha, Solaiman, Bernhardt, Günter, Stadler, Michael, Thol, Felicitas, Heuser, Michael, Eder, Matthias, Ganser, Arnold, Ravens, Sarina, Förster, Reinhold, Prinz, Immo, Koenecke, Christian, Schultze-Florey, Christian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505302/
https://www.ncbi.nlm.nih.gov/pubmed/36142824
http://dx.doi.org/10.3390/ijms231810914
_version_ 1784796438540058624
author Schneider, Jessica
Kuhlmann, Leonie
Xiao, Yankai
Raha, Solaiman
Bernhardt, Günter
Stadler, Michael
Thol, Felicitas
Heuser, Michael
Eder, Matthias
Ganser, Arnold
Ravens, Sarina
Förster, Reinhold
Prinz, Immo
Koenecke, Christian
Schultze-Florey, Christian R.
author_facet Schneider, Jessica
Kuhlmann, Leonie
Xiao, Yankai
Raha, Solaiman
Bernhardt, Günter
Stadler, Michael
Thol, Felicitas
Heuser, Michael
Eder, Matthias
Ganser, Arnold
Ravens, Sarina
Förster, Reinhold
Prinz, Immo
Koenecke, Christian
Schultze-Florey, Christian R.
author_sort Schneider, Jessica
collection PubMed
description Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after allogeneic hematopoietic stem-cell transplantation (alloHSCT). However, DLI harbors the risk of increased non-relapse mortality due to the co-occurrence of graft-versus-host disease (GVHD). GVHD onset may be caused or accompanied by changes in the clonal T-cell receptor (TCR) repertoire. To investigate this, we analyzed T cells in a cohort of 21 patients receiving DLI after alloHSCT. We performed deep T-cell receptor β (TRB) sequencing of sorted CD4(+)CD25(+)CD127(low) regulatory T cells (T(reg) cells) and CD4(+) conventional T cells (T(con) cells) in order to track longitudinal changes in the TCR repertoire. GVHD following DLI was associated with less diverse but clonally expanded CD4(+)CD25(+)CD127(low) T(reg) and CD4(+) T(con) TCR repertoires, while patients without GVHD exhibited healthy-like repertoire properties. Moreover, the diversification of the repertoires upon GVHD treatment was linked to steroid-sensitive GVHD, whereas decreased diversity was observed in steroid-refractory GVHD. Finally, the unbiased sample analysis revealed that the healthy-like attributes of the CD4(+)CD25(+)CD127(low) T(reg) TCR repertoire were associated with reduced GVHD incidence. In conclusion, CD4(+)CD25(+)CD127(low) T(reg) and CD4(+) T(con) TRB repertoire dynamics may provide a helpful real-time tool to improve the diagnosis and monitoring of treatment in GVHD following DLI.
format Online
Article
Text
id pubmed-9505302
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95053022022-09-24 Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion Schneider, Jessica Kuhlmann, Leonie Xiao, Yankai Raha, Solaiman Bernhardt, Günter Stadler, Michael Thol, Felicitas Heuser, Michael Eder, Matthias Ganser, Arnold Ravens, Sarina Förster, Reinhold Prinz, Immo Koenecke, Christian Schultze-Florey, Christian R. Int J Mol Sci Article Donor lymphocyte infusion (DLI) can (re-)induce durable remission in relapsing patients after allogeneic hematopoietic stem-cell transplantation (alloHSCT). However, DLI harbors the risk of increased non-relapse mortality due to the co-occurrence of graft-versus-host disease (GVHD). GVHD onset may be caused or accompanied by changes in the clonal T-cell receptor (TCR) repertoire. To investigate this, we analyzed T cells in a cohort of 21 patients receiving DLI after alloHSCT. We performed deep T-cell receptor β (TRB) sequencing of sorted CD4(+)CD25(+)CD127(low) regulatory T cells (T(reg) cells) and CD4(+) conventional T cells (T(con) cells) in order to track longitudinal changes in the TCR repertoire. GVHD following DLI was associated with less diverse but clonally expanded CD4(+)CD25(+)CD127(low) T(reg) and CD4(+) T(con) TCR repertoires, while patients without GVHD exhibited healthy-like repertoire properties. Moreover, the diversification of the repertoires upon GVHD treatment was linked to steroid-sensitive GVHD, whereas decreased diversity was observed in steroid-refractory GVHD. Finally, the unbiased sample analysis revealed that the healthy-like attributes of the CD4(+)CD25(+)CD127(low) T(reg) TCR repertoire were associated with reduced GVHD incidence. In conclusion, CD4(+)CD25(+)CD127(low) T(reg) and CD4(+) T(con) TRB repertoire dynamics may provide a helpful real-time tool to improve the diagnosis and monitoring of treatment in GVHD following DLI. MDPI 2022-09-18 /pmc/articles/PMC9505302/ /pubmed/36142824 http://dx.doi.org/10.3390/ijms231810914 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schneider, Jessica
Kuhlmann, Leonie
Xiao, Yankai
Raha, Solaiman
Bernhardt, Günter
Stadler, Michael
Thol, Felicitas
Heuser, Michael
Eder, Matthias
Ganser, Arnold
Ravens, Sarina
Förster, Reinhold
Prinz, Immo
Koenecke, Christian
Schultze-Florey, Christian R.
Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
title Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
title_full Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
title_fullStr Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
title_full_unstemmed Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
title_short Healthy-like CD4(+) Regulatory and CD4(+) Conventional T-Cell Receptor Repertoires Predict Protection from GVHD Following Donor Lymphocyte Infusion
title_sort healthy-like cd4(+) regulatory and cd4(+) conventional t-cell receptor repertoires predict protection from gvhd following donor lymphocyte infusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505302/
https://www.ncbi.nlm.nih.gov/pubmed/36142824
http://dx.doi.org/10.3390/ijms231810914
work_keys_str_mv AT schneiderjessica healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT kuhlmannleonie healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT xiaoyankai healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT rahasolaiman healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT bernhardtgunter healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT stadlermichael healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT tholfelicitas healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT heusermichael healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT edermatthias healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT ganserarnold healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT ravenssarina healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT forsterreinhold healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT prinzimmo healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT koeneckechristian healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion
AT schultzefloreychristianr healthylikecd4regulatoryandcd4conventionaltcellreceptorrepertoirespredictprotectionfromgvhdfollowingdonorlymphocyteinfusion